KRISTIN HELLQUIST

- Letter to Congressional Leaders on opposing The Biosimilar Red Tape Elimination Act (S.2305)

- Letter to House Energy and Commerce Committee on RE: Physician Payment Reform Outline - Letter to House Members on Support of H.R. 10073, the Medicare Patient Access and Practice Stabilization Act of 2024 - Supported HR 10073: Medicare Patient Access and Practice Stabilization Act of 2024

- Letter to CMS on 2025 Payment Policies under the Medicare Physician Fee Schedule - Letter to CMS on Medicare and Medicaid Programs; CY 2025 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; Medicare Advantage; Medicare and Medicaid Provider and Supplier Enrollment Policies; and Basic Health Program - Letter to Congressional Leadership to reform Medicare Access and CHIP Reauthorization Act (MACRA)

- Opposed H.R. 1770/S. 2477 - Letter to FDA on Preventing Counterfeit Drugs & Devices (Botox) - Letter to Surgeon General to to renew the Call to Action to Prevent Skin Cancer

- Letter to CMS on Medicare Program; Request for Information on Medicare Advantage Data - Letter to Senate Finance Committee on Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B - Letter to Senate Finance Committee on Bipartisan Medicare GME Working Group Draft Proposal Outline - Supported H.R. 2474, the Strengthening Medicare for Patients and Providers Act

-2/16/2024 Called on FDA to support prioritization of advance notice-and-comment when issuing Level 1 Guidance in response to FDA Draft Report (Docket No. FDA-2023-N-5653) -Supported Finalization of Sunlamp Rule and Amendment to Performance Standard (General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products (Docket No. FDA 2015-N-1765); and the Sunlamp Products; Proposed Amendment to Performance Standard (Docket No. FDA-1988-N-0880) -Called on FDA for Enhanced Patient Safety of Medical Devices for Patients with All Skin Types -Reforms to Increase Affordability and Quality in Employer-Sponsored Health Coverage RFI - makes several recommendations to House Education and Workforce Committee on ways to strengthen and clarify ERISA preemption

AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION

AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION

AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION

AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION

AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION